OGG1 KO Mouse

OGG1 defect together with MYH defect causes greatly increased frequency of lung cancer. Knockout mice have been generated deficient in the OGG1 DNA glycosylase that excises the most frequent mutagenic oxidative base lesion, 8-oxoG.

Contributors

Inventor Institute
Tomas Lindahl Cancer Research UK, London Research Institute: Clare Hall Laboratories
Cat. #: 151577
Research Fields: Cancer;Genetics
Target: OGG1
disease: Lung cancer
Model: Knock-Out
Phenotype: Homozygous -/- mutant mice indistinguishable from their +/- heterozygous and +/+ wild-type siblings
Product description: OGG1 defect together with MYH defect causes greatly increased frequency of lung cancer. Knockout mice have been generated deficient in the OGG1 DNA glycosylase that excises the most frequent mutagenic oxidative base lesion, 8-oxoG. It has been shown that (i) 8-oxoG residues accumulate in the genome to substantially increased levels in the nonproliferating liver of ogg1 null mice; (ii) there is no excision of 8-oxoG initiated by a different DNA glycosylase in cell-free tissue extracts, but there is significant slow repair in an ogg1 null cell line; (iii) the in vivo spontaneous mutation frequency is increased (2- to 3-fold) in liver but not in more rapidly proliferating testis; and (iv) ogg1 null mice do not show an increased tumor incidence, although inactivating mutations in the OGG1 gene have been documented in a small number of sporadic human lung, kidney, gastric, and head-and-neck tumors.
Conditional: No
Genetic background: Briefly, a partial murine OGG1 cDNA clone was isolated by reverse transcription PCR and used to screen a mouse 129SV lambda genomic library. Approximately 4.6 kb of genomic DNA including this motif were replaced by the neomycin-resistance gene/polyadenylation signal (Neo) in the targeting construct by cloning a flanking 3.1-kb XhoI fragment (5') into the XhoI site of pSK-MC1-NEO-poly(A) and a flanking 4.7-kb HindIII fragment (3') into the BamHI site. The targeting vector was electroporated into GK129 embryonic stem (ES) cells from 129SV mice. An ES clone in which homologous recombination had occurred in one allele of the ogg1 gene was expanded from a duplicate plate and injected into blastocysts from C57BL/6J mice. Resultant chimeras were mated and agouti F1 progeny were screened by tail biopsy. Mice heterozygous for the targeted ogg1 allele (+/-) were interbred, and F2 progeny were genotyped.
Production details: Briefly, a partial murine OGG1 cDNA clone was isolated by reverse transcription PCR and used to screen a mouse 129SV lambda genomic library. Approximately 4.6 kb of genomic DNA including this motif were replaced by the neomycin-resistance gene/polyadenylation signal (Neo) in the targeting construct by cloning a flanking 3.1-kb XhoI fragment (5') into the XhoI site of pSK-MC1-NEO-poly(A) and a flanking 4.7-kb HindIII fragment (3') into the BamHI site. The targeting vector was electroporated into GK129 embryonic stem (ES) cells from 129SV mice. An ES clone in which homologous recombination had occurred in one allele of the ogg1 gene was expanded from a duplicate plate and injected into blastocysts from C57BL/6J mice. Resultant chimeras were mated and agouti F1 progeny were screened by tail biopsy. Mice heterozygous for the targeted ogg1 allele (+/-) were interbred, and F2 progeny were genotyped.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Klungland et al. 1999. Proc Natl Acad Sci U S A. 96(23):13300-5. PMID: 10557315.

Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage.

Related Tools for Mouse models

Cat. # Tool Name
151467 p23+/- Mouse Key Info View Tool
151553 Pik3ca RBD mutant Mouse Key Info View Tool
151443 GSTP1GSTP2 KO Mouse Key Info View Tool
151549 Inva3b1 Mouse Key Info View Tool
151554 SAP1 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.